Skip to NavigationSkip to content

News

Pfizer’s Lorviqua (lorlatinib), or Lorbrena as it is known in the US, Canada and Japan, has just been awarded conditional marketing approval from...
Eli Lilly has announced positive results from the Phase 3 EVOLVE-1 and EVOLVE-2 trials looking into Emgality (galcanezumab-gnlm) for the treatment...
AstraZeneca has unveiled new Phase 3 data on the efficacy of Calquence in the treatment of previously-treated patients with chronic lymphocytic...
Brand name prescription drugs cost on average 4.3 times more in the United States than in the UK, according to research from Johns Hopkins...
The number of GPs has been in decline, year on year, since 2014. The decline marks the first sustained fall in the number of NHS GPs for more than...
Cytokinetics has announced at the American Academy of Neurology (AAN) that its fast skeletal muscle troponin activator (FSTA) reldesemtiv fell...
Danish firm Lundbeck has agreed to acquire San Diego-based biotech Abide Therapeutics as part of a deal worth $400 million.
GW Pharma’s Epidiolex has shown positive Phase 3 trial results for the fifth time in a row, after meeting primary endpoints in a randomised, double...
The FDA has approved its first two therapies for the treatment of cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (...
Health Secretary Matt Hancock has said he would not rule out ‘compulsory vaccination,’ as he argued that those spreading anti-vaccine myths had “...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches